Ligand validation:1GCO

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1GCO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1GCO_NAD_A_601	86%	16%	0.084	0.952	2.12	1.75	7	7	2	0	100%	1
1GCO_NAD_B_701	83%	16%	0.089	0.947	2.13	1.73	9	8	2	0	100%	1
1GCO_NAD_F_901	81%	16%	0.09	0.941	2.11	1.74	9	7	2	0	100%	1
1GCO_NAD_E_801	80%	16%	0.089	0.938	2.12	1.72	9	7	1	0	100%	1
1GEE_NAD_B_2262	86%	16%	0.08	0.948	2.14	1.72	9	8	2	0	100%	1
1G6K_NAD_B_2262	61%	15%	0.121	0.91	2.21	1.76	7	9	1	0	100%	1
1RWB_NAD_A_601	54%	16%	0.128	0.892	2.18	1.73	8	9	3	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.